These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multispecies QSAR modeling for predicting the aquatic toxicity of diverse organic chemicals for regulatory toxicology. Singh KP; Gupta S; Kumar A; Mohan D Chem Res Toxicol; 2014 May; 27(5):741-53. PubMed ID: 24738471 [TBL] [Abstract][Full Text] [Related]
5. In silico prediction of toxicity of non-congeneric industrial chemicals using ensemble learning based modeling approaches. Singh KP; Gupta S Toxicol Appl Pharmacol; 2014 Mar; 275(3):198-212. PubMed ID: 24463095 [TBL] [Abstract][Full Text] [Related]
6. The advancement of multidimensional QSAR for novel drug discovery - where are we headed? Wang T; Yuan XS; Wu MB; Lin JP; Yang LR Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095 [TBL] [Abstract][Full Text] [Related]
7. Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data. Trisciuzzi D; Alberga D; Mansouri K; Judson R; Cellamare S; Catto M; Carotti A; Benfenati E; Novellino E; Mangiatordi GF; Nicolotti O Future Med Chem; 2015; 7(14):1921-36. PubMed ID: 26440057 [TBL] [Abstract][Full Text] [Related]
8. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
9. REACH and in silico methods: an attractive opportunity for medicinal chemists. Nicolotti O; Benfenati E; Carotti A; Gadaleta D; Gissi A; Mangiatordi GF; Novellino E Drug Discov Today; 2014 Nov; 19(11):1757-1768. PubMed ID: 24998783 [TBL] [Abstract][Full Text] [Related]
10. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes. Gissi A; Gadaleta D; Floris M; Olla S; Carotti A; Novellino E; Benfenati E; Nicolotti O ALTEX; 2014; 31(1):23-36. PubMed ID: 24247988 [TBL] [Abstract][Full Text] [Related]
11. In Silico Study of In Vitro GPCR Assays by QSAR Modeling. Mansouri K; Judson RS Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474 [TBL] [Abstract][Full Text] [Related]
13. In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors. Xi L; Li S; Yao X; Wei Y; Li J; Liu H; Wu X Arch Pharm (Weinheim); 2014 Nov; 347(11):825-33. PubMed ID: 25363411 [TBL] [Abstract][Full Text] [Related]
14. In Silico 3D Modeling of Binding Activities. Moro S; Sturlese M; Ciancetta A; Floris M Methods Mol Biol; 2016; 1425():23-35. PubMed ID: 27311460 [TBL] [Abstract][Full Text] [Related]
19. The role of different sampling methods in improving biological activity prediction using deep belief network. Ghasemi F; Fassihi A; Pérez-Sánchez H; Mehri Dehnavi A J Comput Chem; 2017 Feb; 38(4):195-203. PubMed ID: 27862046 [TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship models that stand the test of time. Davis AM; Wood DJ Mol Pharm; 2013 Apr; 10(4):1183-90. PubMed ID: 23316903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]